NASDAQ : VBIO
Tivic Health Systems, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.6168 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 547.47K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 474,860 |
| Enterprise Value | 15.78M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 887,589 |
| Shares Outstanding | 887,589 |
| Shares Change (YoY) | +296.62% |
| Shares Change (QoQ) | +17.21% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 14.18% |
| Float | 879,970 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.11 |
| Quick Ratio | 0.69 |
| Debt / Equity | 4.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.38 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -459.52% |
| Return on Assets (ROA) | -57.13% |
| Return on Invested Capital (ROIC) | -83.36% |
| Return on Capital Employed (ROCE) | -57.43% |
| Weighted Average Cost of Capital (WACC) | 6.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$369,808 |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.80 |
| 52-Week Price Change | -99.15% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 14.94 |
| Relative Strength Index (RSI) | 19.90 |
| Average Volume (20 Days) | 1,723,656 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 115,490 |
| Short Previous Month | 87,968 |
| Short % of Shares Out | 13.01% |
| Short % of Float | 13.12% |
| Short Ratio (days to cover) | 0.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.90M |
| Pretax Income | -18.23M |
| Net Income | -19.23M |
| EBITDA | -16.54M |
| EBIT | -16.90M |
| Earnings Per Share (EPS) | -$210.20 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.11M |
| Total Debt | 17.41M |
| Net Cash | -15.30M |
| Net Cash Per Share | -$17.24 |
| Equity (Book Value) | 4.25M |
| Book Value Per Share | 25.57 |
| Working Capital | 336,000 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -14.58M |
| Capital Expenditures | -99,000 |
| Depreciation & Amortization | 365,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -14.67M |
| FCF Per Share | -$16.53 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -296.62% |
| Shareholder Yield | -296.62% |
| Earnings Yield | -39,289.42% |
| FCF Yield | -3,005.90% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |